Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving outcomes for patients with hip osteoarthritis
2014-003412-37Phase 4Completed
- Sponsor
- Keele University
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone acetonide in hip osteoarthritis (2 arms), sponsored by Keele University. Primary endpoint: Hip pain severity (current hip pain). Started Aug 2019; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2014-003412-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003412-37.